Literature DB >> 2244850

Dysregulation of lipid metabolism in Tangier monocyte-derived macrophages.

G Schmitz1, H Fischer, M Beuck, K P Hoecker, H Robenek.   

Abstract

The cellular defect in Tangier mononuclear phagocytes (MNP) was shown to be associated with significant abnormalities in cellular phospholipid, triglyceride, and cholesteryl ester metabolism by using various radiolabeled precursors (32Pi, 3H-serine, 3H-choline, 14C-acetate, and 14C-oleic acid). Tangier MNP expressed increased rates of synthesis for phospholipids (twofold), triglycerides (fivefold), and cholesteryl esters (threefold) as compared to normal MNP when incubated in McCoy's medium containing 0.2% human serum albumin. The turnover rate of cellular phospholipids was also enhanced, while the turnover rates for triglycerides and cholesteryl esters were normal, thus leading to the accumulation of a larger pool of labeled triglycerides and cholesteryl esters in Tangier MNP. The individual phospholipid classes, phosphatidylcholine, sphingomyelin, phosphatidylethanolamine, and phosphatidylserine were similarly affected. Cholesterol loading led to approximately 30% down-regulation of phospholipid synthesis in normal cells, but Tangier MNP showed a smaller response. When nonloaded normal MNP were exposed to high density lipoprotein3 (HDL3), they diminished cellular cholesterol esterification mediated by acyl-CoA:cholesterol acyltransferase (ACAT); in Tangier MNP, ACAT activity increased in the presence of HDL3. When cholesterol-loaded normal and Tangier MNP were treated with HDL3, an up-regulation of phospholipid synthesis was observed in both cell types, but Tangier MNP showed a smaller response. We conclude that the defect in Tangier disease, which we recently described as a "disorder of intracellular traffic" (Schmitz et al. Proc Natl Acad Sci USA 1985;82:6305-6309), is associated with a dysregulation of cellular lipid metabolism, leading to an overproduction of triglycerides and esterified cholesterol and to enhanced synthesis and catabolism of phospholipids.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2244850     DOI: 10.1161/01.atv.10.6.1010

Source DB:  PubMed          Journal:  Arteriosclerosis        ISSN: 0276-5047


  9 in total

1.  Characterization of apoA-I-dependent lipid efflux from adipocytes and role of ABCA1.

Authors:  Alisha D Howard; Philip B Verghese; Estela L Arrese; Jose L Soulages
Journal:  Mol Cell Biochem       Date:  2010-06-10       Impact factor: 3.396

2.  Effect of HDL and apoAI on PGE2 production by monocyte-derived macrophages.

Authors:  Xiaoqin Zhou; Arnold von Eckardstein
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2002

Review 3.  Intracellular cholesterol and phospholipid trafficking: comparable mechanisms in macrophages and neuronal cells.

Authors:  G Schmitz; E Orsó
Journal:  Neurochem Res       Date:  2001-09       Impact factor: 3.996

4.  Coronary artery bypass grafting for a patient with Tangier disease.

Authors:  Hiroshi Takami; Tohru Kobayashi; Tsutomu Nakagawa; Makoto Sakurai; Nobuhisa Awata; Shizuya Yamashita
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2002-09

5.  Phenotype-dependent differences in apolipoprotein E metabolism and in cholesterol homeostasis in human monocyte-derived macrophages.

Authors:  P Cullen; A Cignarella; B Brennhausen; S Mohr; G Assmann; A von Eckardstein
Journal:  J Clin Invest       Date:  1998-04-15       Impact factor: 14.808

6.  The pathology of cornea in Tangier disease (familial high density lipoprotein deficiency).

Authors:  A F Winder; R Alexander; A Garner; D Johnston; D Vallance; G McCreanor; J Frohlich
Journal:  J Clin Pathol       Date:  1996-05       Impact factor: 3.411

7.  Defective regulation of phosphatidylcholine-specific phospholipases C and D in a kindred with Tangier disease. Evidence for the involvement of phosphatidylcholine breakdown in HDL-mediated cholesterol efflux mechanisms.

Authors:  M Walter; H Reinecke; U Gerdes; J R Nofer; G Höbbel; U Seedorf; G Assmann
Journal:  J Clin Invest       Date:  1996-11-15       Impact factor: 14.808

8.  Defective removal of cellular cholesterol and phospholipids by apolipoprotein A-I in Tangier Disease.

Authors:  G A Francis; R H Knopp; J F Oram
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

9.  Postprandial hypertriglyceridaemia in patients with Tangier disease.

Authors:  G Kolovou; D Daskalova; K Anagnostopoulou; I Hoursalas; V Voudris; D P Mikhailidis; D V Cokkinos
Journal:  J Clin Pathol       Date:  2003-12       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.